PATIENTS.

At Regulus, patients are at the heart of all our efforts. We work with patient advocacy organizations to enhances our ability to better understand our patients and their needs. Successful clinical trials are not possible without the participation of patients and the support of their families. We are grateful for the interest and participation in our clinical trials.

If you have any questions about our clinical trials, please speak with your physician or contact info@regulusrx.com.

Current Clinical Trials.

Indication
Program
Trial Number
Trial Name
Autosomal dominant polycystic kidney disease (ADPKD)
RGLS8429
Phase 1b; A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

Resources.

The following is a list of reliable resources for patients and families with reliable information related to kidney health and clinical trials.

ClinicalTrials.Gov

ClinicalTrials.gov is a registry with information about the location of clinical trials, their design and purpose, and eligibility criteria. Search the database for Regulus trials or other clinical trials: www.clinicaltrials.gov

Center for Information and Research on Clinical Research Participation (CISCRP)

CISCRP is a nonprofit organization dedicated to educating and informing the public, patients, medical/research communities, the media, and policy makers about clinical research. www.ciscrp.org

Advocacy Partners.

The following is a list of our advocacy partners, who can provide patients and families with reliable information related to kidney health and clinical trials.

The NKF is a major non-profit health organization focused on awareness, education, prevention and treatment of kidney disease. www.kidney.org

NORD, along with its more than 300 patient organization members, is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient services. www.rarediseases.org

The PKD Foundation is a United States non-profit organization that funds research into polycystic kidney disease. It is the second-largest U.S.-based funder of PKD research after the National Institutes of Health. www.pkdcure.org